Statements of Shareholders' Deficiency - USD ($)	12 Months Ended
	Jan. 31, 2018	Jan. 31, 2017
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock, shares outstanding, beginning balance (in shares)	1,233,853
Shareholders' deficiency, beginning balance	$ (509,639)	$ (421,404)
Net loss	$ (85,963)	$ (88,235)
Common stock, shares outstanding, ending balance (in shares)	1,233,853	1,233,853
Shareholders' deficiency, ending balance	$ (595,602)	$ (509,639)
Common Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock, shares outstanding, beginning balance (in shares)	1,233,853	1,233,853
Shareholders' deficiency, beginning balance	$ 1,233	$ 1,233
Common stock, shares outstanding, ending balance (in shares)	1,233,853	1,233,853
Shareholders' deficiency, ending balance	$ 1,233	$ 1,233
Additional Paid-in Capital
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shareholders' deficiency, beginning balance	81,323	81,323
Shareholders' deficiency, ending balance	81,323	81,323
Accumulated Deficit
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shareholders' deficiency, beginning balance	(592,195)	(503,960)
Net loss	(85,963)	(88,235)
Shareholders' deficiency, ending balance	$ (678,158)	$ (592,195)